Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01372995 · ClinicalTrials.gov registry record · Phase 2
Vitamin D in Ventilated ICU Patients
A Phase 2 study of Respiratory Failure, sponsored by Emory University.
- Completed
- Registry status
- Phase 2
- Development phase
- 31
- Enrollment target
- 2
- Study locations
NCT01372995 is a Phase 2 study of Respiratory Failure that has completed, run by Emory University. The registered enrollment target is 31 participants, below the 4,523-participant average among 40 other Respiratory Failure trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT01372995, a Phase 2 study of Respiratory Failure, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 31 participants
- Enrollment target
- 2
- Study locations
Study Summary
The increasing rate of hospital-acquired infection and antibiotic resistance are major causes of prolonged ICU stay and death in hospitalized patients. The enormous impact of ICU-related infection demands the need for cost-effective therapies that can be rapidly implemented to improve patient immune response to control infection. Unfortunately, little high-quality comparative effectiveness research has been performed on micronutrient treatment regimens as methods to decrease hospital-acquired infection in critically ill patients. Critically ill medical and surgical patients have an extremely high prevalence of vitamin D insufficiency. We will perform a rigorous, double-blind, randomized, controlled, pilot clinical trial in ventilator-dependent ICU patients to test the clinical/metabolic safety and efficacy of two doses of oral high-dose vitamin D3 therapy versus standard therapy (no supplemental vitamin D). The primary endpoint is to test whether high-dose regimens \[either 50,000 or 100,000 international units (IU) of enteral vitamin D3 given daily for 5 consecutive days (total dose = 250,000 or 500,000 IU, respectively) increase plasma 25(OH)D concentrations into a desirable range (\> 30 ng/mL).
Conditions Studied
Interventions
- DRUG Enteral Vitamin D3 50,000 IU
- DRUG Enteral Vitamin D3 100,000IU
- OTHER Inactive substance
Study Locations (2)
Georgia
- Emory University Hospital Midtown - Atlanta
- Emory University Hospital - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2011-07 |
| Est. Completion | 2014-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01372995
The ClinicalTrials.gov registry entry for NCT01372995 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,523-participant average among 40 other Respiratory Failure trials with a reported enrollment target (99% lower). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Respiratory Failure appearing as the primary indexed condition, and to 3 interventions - of which Enteral Vitamin D3 50,000 IU is the first listed.
NCT01372995 reports 2 study locations spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT01372995 about?
NCT01372995 is a clinical study titled "Vitamin D in Ventilated ICU Patients". The increasing rate of hospital-acquired infection and antibiotic resistance are major causes of prolonged ICU stay and death in hospitalized patients. The enormous impact of ICU-related infection demands the need for cost-effective therapies that can be rapidly implemented to improve patient immune...
What is the current status of trial NCT01372995?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 31 participants. The study started on 2011-07. Estimated completion is 2014-04.
What conditions does trial NCT01372995 study?
This clinical trial studies the following conditions: Respiratory Failure.
What interventions are being tested in trial NCT01372995?
The interventions under investigation include: Enteral Vitamin D3 50,000 IU (DRUG), Enteral Vitamin D3 100,000IU (DRUG), Inactive substance (OTHER).
Who is sponsoring clinical trial NCT01372995?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01372995 being conducted?
This trial has 2 study locations across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Respiratory Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
CYCLE Pilot Randomized Trial
COMPLETED · Phase 2
-
Ganciclovir/Valganciclovir for Prevention of CMV Reactivation in Acute Injury of the Lung and Respiratory Failure
COMPLETED · Phase 2
-
Analgesia-First Sedation in Trauma Patients
RECRUITING · NA
-
Hospital Airway Resuscitation Trial
RECRUITING · NA
-
Supraglottic Airway for Resuscitation in Preemies
RECRUITING · NA
-
The Family Perspectives Project Pilot Trial
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.